Interesting they mention secondary sales at an even higher valuation. I wonder how recent they were since plant food is very much out of favour. Beyond is down two thirds since Impossible mooted it’s $10b IPO so no idea why shareholders think they can get away with that in secondaries now (clearly it’s working).